Prostate cancer advances help extend a patient's life

September 11, 2018 | Dory Benford

Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.

Continue Reading

A mind-body approach to treating kidney cancer patients

August 13, 2018 | Zen Vuong

Patients with metastatic kidney cancer who have high rates of distress tend to have poorer overall survival compared to those with low distress, according to a new study by City of Hope researchers.

City of Hope Researchers Publish First Report on a Protein Inhibitor for Advanced Bladder Cancer

June 8, 2018 | Letisia Marquez

Advanced bladder cancer is particularly difficult to treat. The five-year survival rate for Stage 4 bladder cancer is only about 15 percent. Now, City of Hope researchers have discovered a that a novel drug blocks a key protein that drives the disease.

Don Nelson: Biking for Hope

December 27, 2017 | Maxine Nunes

Don Nelson, a 68-year-old metastatic kidney cancer patient, bicycles 200 miles a month and says life is even better now than before the disease struck.

A ‘Multifront’ Approach: Breakthroughs in Bladder Cancer

May 16, 2017 | Abe Rosenberg

Bladder cancer is a stubborn disease. Malignant cells in the bladder frequently grow back or pop up elsewhere, even if they're removed in their earliest stages. But the City of Hope surgeons and scientists working to eradicate bladder cancer are equally stubborn.

World Cancer Day: New treatments and cures start with collaborations

February 3, 2017 | Denise Heady

Defeating cancer cannot be done alone. It requires a team approach. Here are just a few examples of how City of Hope scientists and physicians are working together to create leading-edge approaches to end cancer.

Can a vasectomy increase your risk of prostate cancer?

September 29, 2016 | Denise Heady

There are many risk factors that can increase the risk of prostate cancer - largely smoking and obesity - but a new study suggests a vasectomy isn’t one of them.

ASCO 2016: Where Cancer Breakthroughs Happen

June 3, 2016 | Sumanta Kumar Pal, M.D.

Sumanta Kumar Pal, M.D., offers insights into ASCO 2016. Here, he has distilled some of the main themes at this year's conference such as the Cancer Moonshot Program, and personalized and precision medicine.

Bladder cancer 2016: 'Coordinated care pathways' and immunotherapy

January 1, 2016 | Veronique de Turenne

Shorter hospital stays and reduced readmission rates – those are the goals for bladder cancer patients at City of Hope in 2016. Uniquely coordinated care will make that possible.

Metastatic kidney cancer patient Bill Geske: what I learned

November 9, 2015 | Denise Heady

As a business owner and father of two, 50-year-old Bill Geske was satisfied with his personal and professional life. His general engineering business was thriving with the help of his son and wife, and he had just sent his daughter off to college.

But then, during a trip with Diane, his wife of 32 years, to visit their daughter, Bill began having stomach pains and noticed blood in his urine.

Precision Medicine: What It Means Now. What It Means In The Future

August 25, 2015 | Veronique de Turenne

Welcome to the brave new world of precision medicine, in which the diseases themselves can point to a treatment and even a cure. What was once dismissed as futuristic has now become reality for some cancer patients.